<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        41-73-11
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2011
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        VERSATIS 5% MEDICATED PLASTER
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LIDOCAINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Topical
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Medicated plaster
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Box
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        98.05
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="TEIKOKU SEIYAKU" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            TEIKOKU SEIYAKU
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 392]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            AL-KAMAL IMPORT OFFICE CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            STADA ARZNEIMITTEL GmbH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        D04AB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        C05AD01
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Versatis contains lidocaine, a local analgesic, which works by reducing the<br />pain in your skin.<br />You have been given Versatis to treat a painful skin condition called postherpetic<br />neuralgia. This is generally characterised by localised symptoms<br />such as burning, shooting or stabbing pain.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- if you are allergic to lidocaine or any of the other ingredients of this medicine<br />(listed in section 6).<br />- if you have had an allergic reaction to other products which are similar to<br />lidocaine, such as bupivacaine, etidocaine, mepivacaine or prilocaine.<br />- on injured skin or open wounds</p><p>&nbsp;</p><p>Warnings and precautions.</p><p>Talk to your doctor or pharmacist before using Versatis If you have severe liver disease, or severe heart problems, or severe kidney problems, you should talk to your doctor before using Versatis. Versatis should only be used on the areas of skin after the shingles has healed. It should not be used on or near the eyes or mouth.</p><p>Children and adolescents: Versatis has not been studied in patients under 18 years of age. Therefore it is not recommended for use in this patient population Lidocaine is broken down in your liver to several compounds. One of these compounds is 2,6 xylidine which has been shown to cause tumours in rats when given lifelong in very high doses. The significance of these findings in humans is not known.</p><p>Other medicines and Versatis Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>Pregnancy, breast-feeding and fertility If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Versatis should not be used in pregnancy unless clearly necessary. There are no studies of the plaster in breast-feeding women. When using Versatis, only very small amounts of the active substance lidocaine may be present in the blood stream. An effect on breast-fed infants is unlikely.</p><p>Driving and using machines An effect of Versatis on the ability to drive and use machines is unlikely. Therefore you may drive or operate machinery whilst using Versatis.</p><p>Versatis contains propylene glycol, methyl parahydroxybenzoate and propyl parahydroxybenzoate. The plasters contain propylene glycol (E1520) which may cause skin irritation. In addition it contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) which may cause allergic reactions. The allergic reactions may sometimes occur after you have been using the plaster for some time</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Step 1: open the sachet and remove one or more plasters<br />&bull; tear open or cut the sachet along the dotted line<br />&bull; when using scissors, be careful not to damage the plasters<br />&bull; take out one or more plasters depending on the size of the painful area on<br />your skin<br />Step 2: close the sachet<br />&bull; close the sachet tightly after use<br />&bull; the plaster contains water, and will dry out if<br />the sachet is not closed properly.<br />Step 3: cut the plaster, if necessary<br />&bull; if required, cut the plaster to the required<br />size to fit the painful area of skin before<br />removing the liner.<br />Step 4: remove the liner<br />&bull; remove the transparent liner from the<br />plaster<br />&bull; try not to touch the sticky part of the plaster<br />Step 5: apply the plaster and press it firmly onto the skin<br />&bull; apply up to three plasters to the painful<br />area of skin<br />&bull; press the plaster onto your skin<br />&bull; press for at least 10 seconds to make sure<br />the plaster sticks firmly<br />&bull; make sure that all of it sticks to your skin,<br />including the edges<br />Leave the plaster on for 12 hours only<br />It is important that Versatis is in contact with your skin for only 12 hours. For<br />example, if you have more pain at night you might want to apply the plaster at<br />7pm in the evening and remove it at 7am in the morning.<br />If you have more pain during the day than at night you might want to apply<br />Versatis at 7am in the morning, and remove it at 7pm in the evening.</p><p>Bathing, showering and swimming: If at all possible contact with water should be avoided whilst using Versatis. Bathing, showering or swimming can be done in the time period when you are not wearing the plaster. If you have had a recent bath or shower, you should wait until your skin cools before using the plaster.</p><p>If the plaster comes off Very rarely the plaster might fall off, or come unstuck. If it does, try sticking it back on the same area. If it does not stay on, remove it and put a new plaster on the same area. How to remove Versatis When changing the plaster, remove the old plaster slowly. If it does not come off easily, you can soak it in warm water for a few minutes before removing the plaster.</p><p>If you forget to remove the plaster after 12 hours As soon as you remember, remove the old plaster. A new plaster can be used again after 12 hours.</p><p>If you use more plasters than you should If you use more plasters than necessary or wear them for too long, this may increase the risk of getting side effects.</p><p>If you forget to use Versatis After the 12 hour period with no plaster, if you have forgotten to use a new plaster, you should stick on a new plaster as soon as you remember. If you have any further questions on use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not<br />everybody gets them.<br />Important side effects or symptoms to look out for and what to do if<br />you are affected:<br />If irritation or burning sensation occurs whilst you are using the plaster, the<br />plaster should be removed. The area of irritation should remain plaster free<br />until the irritation stops.</p><p>Other side effects may occur: Very common (May affect more than 1 in 10 people): Skin conditions at or around the site of plaster application, which may include redness, rash, itching, burning, dermatitis, and small blisters.</p><p>Uncommon (May affect up to 1 in 100 people): Skin injury and skin wounds Very rare May affect up to 1 in 10,000 people): Open wound, severe allergic reaction and allergy.</p><p>If you get any side effects, talk to your doctor or pharmacist.</p><p>This includes any possible side effects not listed in this leaflet. By reporting side affects you can help provide more information on the safety of this medicine</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Used plasters still contain active ingredient, which may be harmful to others. Fold the used plasters in half, with the sticky sides together and throw them away so that they are out of the reach of children. Do not throw away medicines via wastewater or household waste.</p><p>Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- The active substance is lidocaine. - Each 10 cm x 14 cm plaster contains 700 mg (equivalent to 5% w/w) lidocaine - The other ingredients in the plaster (excipients) are glycerol, liquid sorbitol, carmellose sodium, propylene glycol (E1520), urea, heavy kaolin, tartaric acid, gelatin, polyvinyl alcohol, aluminium glycinate, disodium edetate, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), polyacrylic acid, sodium polyacrylate, purified water. Backing fabric and release liner: polyethylene terephthalate (PET)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                The medicated plaster is 14 cm long and 10 cm wide. It is white and made 
of fleece fabric marked with “lidocaine 5%”. The plasters are packed in resealable sachets, each containing 5 plasters.
Each carton contains 5, 10, 20, 25 or 30 plasters packed in 1, 2, 4, 5 or 6 
sachets, respectively. Not all pack sizes may be marketed
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gr&uuml;nenthal GmbH &ndash; 52099 Aachen - Germany Tel: + 49-241-569-0 Fax: +49-241-569-1498</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in10\2018.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>فرساتيس يحتوي على ليدوكايين، و هو مسكن موضعي، يعمل على تقليل الألم على الجلد.</p><p>تم اعطائك فرساتيس لعلاج حالة جلدية مؤلمة تسمى الألم العصبي بعد الاصابة بالهربس. تتسم بصفة عامة بأعراض موضعية مثل الاحساس بالحرقان، ألم حاد متنقل أو شديد الوخز.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>- اذا كنت تعاني من أرجية ( فرط حساسية) تجاه ليدوكايين أو تجاه أي من المكونات الاخرى في فرساتيس - اذا كان قد سبق لك الاصابة بتفاعل حساسية تجاه منتجات أخرى مشابهة لليدوكايين، مثل بوبيفاكايين، اتيدوكايين، ميبيفاكايين أو بريلوكايين.</p><p>توخى الحذر الخاص مع فرساتيس اذا كنت مصاب بمرض كبدي شديد، أو مشاكل شديدة بالقلب، أو مشاكل شديدة بالكلى، ينبغي في هذه الحالة أن تتحدث مع طبيبك الخاص قبل استخدام فرساتيس. يستخدم فرساتيس على مناطق من الجلد فقط عقب الشفاء من الهربس النطاقي.</p><p>لا ينبغي استخدامه على العين أو الفم أو بالقرب منهما. لم يتم دراسة استخدام فرساتيس على المرضى الذين يبلغون أقل من 18 عام. لذلك لا ينصح باستخدامه في هذه الفئة من المرضى. ينحل ليدوكايين داخل الكبد إلى عدة مركبات. أحد هذه المركبات هو 6،2 زايليدين و الذي تبين تسببه في الاصابة بأورام في الجرذان عند اعطائه لهم مدى الحياة بجرعات كبيرة للغاية. دلالة هذه النتائج لدى الانسان تعتبر غير معروفة.</p><p>تناول أدوية أخرى ً بأخذ أي أدوية أخرى بما في ذلك الأدوية يرجى ابلاغ طبيبك الخاص أو الصيدلي اذا كنت تأخذ أو قمت مؤخرا التي يتم الحصول عليها بدون وصفة طبية.</p><p>الحمل و الرضاعة الطبيعية و الخصوبة&nbsp; &nbsp;استشيري طبيبك الخاص أو الصيدلي قبل أخذ هذا الدواء ِ انك اذا حاملا ً او كنت ترضعين. أو&nbsp; اذا ظننت انك&nbsp;ربما تكونين حاملا او لو كنت تخططين للحمل لا ينبغي استخدام فرساتيس خلال فترة الحمل ما لم تكن هناك ضرورة ملحة. لا توجد دراسات عن استخدام البلاستر من جانب السيدات المرضعات.</p><p>ربما تتواجد كميات ضئيلة للغاية فقط من المادة الفعالة ليدوكايين بمجرى الدم مع استخدام فرساتيس. ليس من المرجح أن يكون هناك تأثير على الرضع الذين يرضعون رضاعة طبيعية.</p><p>القيادة و استخدام الآلات من غير المرجح أن يكون هناك تأثير لـ فرساتيس على القيادة و استخدام الآلات. لذلك يمكنك القيادة أو تشغيل الآلات أثناء استخدام فرساتيس.</p><p>&nbsp;</p><p>معلومات هامة بخصوص بعض مكونات فرساتيس يحتوي البلاستر على بروبايلين جلايكول ( اي1520 )و الذي يمكن أن يسبب تهيج الجلد. بالاضافة لذلك، يحتوي على مثيل باراهيدروكسي بنزوات (اي 218 )و بروبيل باراهيدروكسي بنزوات (اي 216&nbsp;)و اللذان قد يتسببا في تفاعلات حساسية. قد تحدث تفاعلات الحساسية في بعض الأحيان بعد أن تكون قد استخدمت البلاستر لبعض الوقت.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>استخدم فرساتيس دائم&nbsp; على النحو الذي أخبرك به طبيبك الخاص. ينبغي عليك التحقق من طبيبك الخاص أو استخدم فرساتيس دائما الصيدلي اذا لم تكن متأكدا ً.&nbsp;</p><p>&nbsp;</p><p>لمقاس المناطق المؤلمة على جلدك. الجرعة اليومية المعتادة هي استخدام ما بين واحد إلى ثلاثة بلاستر وفقا يمكن قطع فرساتيس إلى قطع أصغر لتناسب المنطقة المصابة.</p><p>لا ينبغي عليك استخدام أكثر من 3 بلاستر في نفس الوقت.</p><p>ينبغي نزع البلاستر عقب 12 ساعة من الاستخدام، فبذلك يكون هناك فترة زمنية تبلغ 12 ساعة بدون استخدام للبلاستر، يمكن أن تختار وضع فرساتيس خلال النهار أو أثناء الليل.</p><p>في العادة، قد تشعر ببعض تخفيف للألم في اليوم الأول لاستخدامك البلاستر، لكن قد يستغرق الأمر ما قد يصل إلى 2-4 أسابيع حتى مشاهدة تأثير فارستيس الكامل في تخفيف الألم. لو كنت لا تزال تعاني من كثير من الألم بعد هذا الوقت، يرجى التحدث مع طبيبك الخاص لأنه يجب في هذه الحالة تقييم فوائد العلاج مقابل المخاطر المحتملة ( انظر بند 2&quot; توخى الحذر الخاص مع فرساتيس&quot;).</p><p>سوف يتحقق الطبيب من مدى كفاءة عمل فرساتيس على فترات منتظمة.</p><p>قبل أن تلصق فرساتيس على المنطقة المصابة:</p><p>- اذا كانت المنطقة المصابة عليها شعر، يمكنك قص الشعر باستخدام المقص. لا تقم بحلقه. - يجب أن يكون الجلد نظيف و جاف. - يمكن استخدام الكريمات و اللوشن على الجلد المصاب خلال الفترة التي لا تقوم فيها بوضع البلاستر. ً قبل ً بالاغتسال أو الاستحمام، ينبغي عليك الإنتظار حتى يصير جلدك باردا - اذا كنت قد قمت مؤخرا استخدام البلاستر.</p><p>الخطوة رقم 1 :افتح الكيس و انزع واحد أو أكثر من البلاستر</p><p>- قم بتمزيق أو قطع الكيس على امتداد الخط المنقط</p><p>- عند استخدامك للمقص، احرص على عدم الاضرار بالبلاستر ً لمقاس المنطقة المؤلمة من جلدك</p><p>- أخرج واحد أو اكثر من البلاستر وفق&nbsp;لمقاس المنطقة المؤلمة من جلدك</p><p>الخطوة رقم 2 :اغلق الكيس</p><p>- اغلق الكيس بإحكام عقب الاستخدام</p><p>- البلاستر يحتوي على الماء، و سوف يجف اذا لم يتم اغلاق الكيس بشكل سليم.</p><p>الخطوة رقم 3 :اقطع البلاستر، اذا لزم الأمر</p><p>- اذا كان ضروري، اقطع البلاستر للمقاس المطلوب حتى يناسب المنطقة المؤلمة من الجلد قبل نزع البطانة.</p><p>الخطوة رقم 4 :انزع البطانة - انزع البطانة الشفافة من البلاستر</p><p>- حاول عدم لمس الجانب اللاصق من البلاستر</p><p>الخطوة قم 5 :ضع البلاستر و اضغط عليه بقوة على الجلد</p><p>- يمكنك وضع ما يصل إلى إلى ثلاثة بلاستر على المنطقة المؤلمة من الجلد</p><p>- اضغط البلاستر على الجلد ً - اضغط لمدة 10 ثواني على الأقل لتتأكد من التصاق البلاستر جيدا</p><p>- تأكد من التصاقه بأكمله على جلدك بما في ذلك الأطراف.</p><p>اترك البلاستر على الجلد لمدة 12 ساعة فقط</p><p>من المهم أن يظل فرساتيس ملامس للجلد لمدة 12 ساعة فقط. على سبيل المثال، اذا كنت تعاني من مزيد &nbsp;من الألم خلال الليل قد ترغب في وضع البلاستر في الساعة 7 ليلا ً و نزعه الساعة 7 صباحا</p><p>اذا كنت تعاني من الألم خلال النهار أكثر من الليل قد ترغب في وضع فرساتيس في الساعة 7 ، و صباحا .ً نزعه الساعة 7 ليلا</p><p>الاغتسال، الاستحمام و السباحة :ينبغي تجنب أي اتصال محتمل مع الماء خلال استخدام فرساتيس. يمكنك الاغتسال، أو الاستحمام أو ً السباحة أثناء الفترة الزمنية التي لا تضع خلالها البلاستر. بالاستحمام، ينبغي عليك اذا كنت قد قمت ا مؤخر ً قبل استخدام البلاستر. الانتظار حتى يصبح جلدك باردا</p><p>اذا انفصل البلاستر قد يسقط البلاستر أو ينفك في أحوال نادرة للغاية. اذا حدث ذلك، حاول لصقه مرة أخرى على نفس المنطقة. اذا لم يبقى على الجلد، انزعه و ضع بلاستر جديد على نفس المنطقة.</p><p>كيف تنزع فرساتيس عند تغيير البلاستر، انزع البلاستر القديم ببطء. اذا لم ينفصل بسهولة، يمكنك تبليله بماء دافىء لدقائق قليلة قبل نزع البلاستر.</p><p>اذا نسيت نزع البلاستر بعد 12 ساعة انزع البلاستر القديم بمجرد أن تتذكر. يمكن استخدام بلاستر جديد مرة أخرى بعد 12 ساعة.</p><p>اذا استخدمت عدد من البلاستر أكثر مما يجب اذا استخدمت عدد من البلاستر أكثر من الضروري أو اذا وضعتهم لفترة طويلة جدا زيد ذلك الأمر من ً، قد ي خطر التعرض للآثار الجانبية.</p><p>اذا نسيت استخدام فرساتيس لو نسيت استخدام بلاستر جديد بعد مرور الفترة الزمنية التي تبلغ 12 ساعة بدون بلاستر، يجب عليك لصق بلاستر جديد بمجرد أن تتذكر.</p><p>اذا كان لديك أي أسئلة أخرى بخصوص استخدام هذا المنتج، يمكنك سؤال طبيبك الخاص أو الصيدلي.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>شأنه شأن الأدوية الأخرى، يمكن أن يسبب فرساتيس اثارا جانبية و ذلك على الرغم من عدم تعرض الجميع لها.</p><p>&nbsp;</p><p>اذا حدث تهيج أو شعور بالحرقان أثناء استخدام البلاستر، ينبغي في هذه الحالة نزع البلاستر. المنطقة المصابة بالتهيج يجب أن تظل بدون بلاستر حتى زوال التهيج.</p><p>اذا اشتدت أي من الآثار الجانبية، أو اذا لاحظت أي آثار جانبية لم يرد ذكرها في هذه النشرة، يرجى ابلاغ طبيبك الخاص أو الصيدلي. ً</p><p>&nbsp;</p><p>الآثار الجانبية الشائعة جدا و التي يمكن ان تصيب أكثر من شخص واحد من كل 10 أشخاص مذكورة الآثار الجانبية الشائعة جدا بأسفل.</p><p>تشمل حالات جلدية عند مكان وضع البلاستر أو حوله، و قد تشمل احمرار، طفح جلدي، حكة، احساس بالحرقان، التهاب جلدي، و بثور صغيرة.</p><p>&nbsp;</p><p>الآثار الجانبية غير الشائعة و التي يمكن أن تصيب ما يصل إلى شخص واحد من كل 100 شخص مذكورة بأسفل.</p><p>اصابة الجلد و جروح الجلد ً</p><p>&nbsp;</p><p>الآثار الجانبية النادرة جدا و التي يمكن أن تصيب ما يصل إلى شخص واحد من كل 000.10 شخص الآثار الجانبية النادرة جدا مذكورة بأسفل.</p><p>جرح مفتوح، تفاعل حساسية شديد و أرجية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيدا لا تستخدم فرساتيس بعد تاريخ انتهاء الصلاحية المذكور على الكيس و العلبة.</p><p>تاريخ انتهاء الصلاحية يشير إلى اليوم الأخير من ذلك الشهر.</p><p>لا يحفظ بالثلاجة و لا يجمد. يخزن في درجة حرارة لا تتجاوز 30 ْم.</p><p>بعد الفتح للمرة الأولى: احتفظ بالكيس محكم الاغلاق. بعد فتح الكيس، ينبغي استخدام البلاستر في غضون 14 يوم.</p><p>لا تستخدم فرساتيس اذا لاحظت تلف الكيس. اذا حدث ذلك، ربما يجف البلاستر و يصير أقل التصاق.</p><p>&nbsp;</p><p>كيف تتخلص من فرساتيس:</p><p>البلاستر المستخدم مازال يحتوي على المادة الفعالة و التي يمكن أن تكون ضارة للآخرين.</p><p>قم بطي ً البلاستر المستخدم من المنتصف مع ضم الجوانب اللاصقة مع بعضها البعض و قم بالقائه عن بعيدا متناول الأطفال.</p><p>لا ينبغي التخلص من الأدوية عبر مياه الصرف الصحي و النفايات المنزلية.</p><p>اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. سوف تساعد هذه الاجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>- المادة الفعالة هي ليدوكايين</p><p>- كل بلاستر 10 سم &times; 14 سم يحتوي على 700 مجم ( 5&nbsp;)%ليدوكايين</p><p>- المكونات الأخرى في البلاستر عبارة عن جليسرول، سوربيتول سائل، كارمللوز صوديوم، بروبايلين جلايكول ( اي1520 ،(يوريا، كاولين ثقيل، حمض التارتاريك، جيلاتين، كحول البولي فينيل، الومينيوم جليسينات، اديتات ثنائي الصوديوم، ميثيل بارا هيدروكسي بنزوات ( اي 218 ،(بروبيل بارا هيدروكسي بنزوات (اي 216 ،(حمض البولي اكريليك، صوديوم بولي اكريلات، ماء نقي.</p><p>النسيج الداعم و البطانة: بولي ايثيلين تيريفثالات (PET)</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>يبلغ طول البلاستر الدوائي 14 سم و عرضه 10 سم. أبيض اللون و مصنوع من نسيج الصوف موسوم برمز &quot; %5 lidocaine .&quot; البلاستر معبأ في أكياس قابلة لإعادة الاغلاق، كل منها تحتوي على 5 بلاستر.</p><p>كل علبة تحتوي على 5 ،10 ،20 ،25 أو 30 بلاستر معبأ في 1 ،2 ،4 ،5 أو 6 أكياس بالترتيب. ربما لا يتم تسويق جميع أحجام العبوة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>جروننتال شركة مساهمة ذات مسئولية محدودة &ndash; 52099 آخن &ndash; ألمانيا</p><p>+49-241-569-0 :ت</p><p>ت : 0-569-241-49+</p><p>فاكس: 1498-569-241-49+</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت المراجعة الأخيرة لهذه النشرة في 09/2015
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Versatis 700 mg Medicated Plaster
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each plaster (10 cm x 14 cm) contains 700 mg lidocaine (5% w/w)

Excipients with known effect:
Methyl-4-hydroxybenzoate (E218) (Ph. Eur.) 14 mg 
Propyl-4-hydroxybenzoate (E216) (Ph. Eur.) 7 mg 
Propylene glycol (E1520) 700 mg
For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Medicated plaster.

White hydrogel plaster consisting of an adhesive layer which is applied to a non-woven polyethylene terephthalate backing embossed with “Lidocaine 5%” and covered with a protective polyethylene terephthalate film release liner.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Versatis it is indicated for the symptomatic relief of neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia, PHN) in adults.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adults and elderly patients</p><p>The painful area should be covered with the plaster once daily for up to 12&nbsp;hours within a 24&nbsp;hours period.&nbsp; Only the number of plasters that are needed for an effective treatment should be used.&nbsp; When needed, the plasters may be cut into smaller sizes with scissors prior to removal of the protective release liner.&nbsp; In total, not more than three plasters should be used at the same time.</p><p>The plaster must be applied to intact, dry and non-irritated skin (after healing of the shingles).</p><p>Each plaster must be worn no longer than 12&nbsp;hours.&nbsp; The subsequent plaster-free interval must be at least 12&nbsp;hours.&nbsp; The plaster can be applied during the day or during the night.</p><p>The plaster must be applied to the skin immediately after removal from the sachet and following removal of the protective release liner from the gel surface.&nbsp; Hairs in the affected area must be cut off with a pair of scissors (not shaved).</p><p>Treatment outcome should be re-evaluated after 2-4 weeks.&nbsp; If there has been no response to treatment after this period (during the wearing time and/or during the plaster-free interval),<br />&nbsp;</p><p>&nbsp;</p><p>treatment with Versatis must be discontinued as potential risks may outweigh benefits in this context (see sections 4.4 and 5.1). &nbsp;Long-term use of Versatis in clinical studies showed that the number of plasters used decreased over time. &nbsp;Therefore, treatment should be reassessed at regular intervals in order to decide whether the amount of plasters needed to cover the painful area can be reduced, or if the plaster-free period can be extended.</p><p><em>Renal impairment</em></p><p>In patients with mild or moderate renal impairment a dosage adjustment is not required.&nbsp; Versatis should be used with caution in patients with severe renal impairment (see section 4.4).</p><p>&nbsp;</p><p><em>Hepatic impairment</em></p><p>In patients with mild or moderate hepatic impairment a dosage adjustment is not required.&nbsp; Versatis should be used with caution in patients with severe hepatic impairment (see section&nbsp;4.4).</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>The safety and efficacy of Versatis in children below 18&nbsp;years of age has not been established.&nbsp; No data are available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.  The plaster is also contraindicated in patients with known hypersensitivity to other local anesthetics of the amide type, such as bupivacaine, etidocaine, mepivacaine and prilocaine.

The plaster must not be applied to inflamed or injured skin areas (such as active herpes zoster lesions), atopic dermatitis or wounds.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The plaster should not be applied to mucous membranes. &nbsp;Eye contact with the plaster should be avoided.</p><p>&nbsp;</p><p>The plaster should be used with caution in patients with severe cardiac impairment, severe renal impairment or severe hepatic impairment.</p><p>&nbsp;</p><p>Mixed to their diet, one of the lidocaine metabolites, 2,6 xylidine, has been shown to be genotoxic and carcinogenic in rats (see section 5.3).&nbsp; Secondary metabolites have been shown to be mutagenic.&nbsp; The clinical significance of these studies is unknown.&nbsp; Consequently, long‑term treatment with Versatis is only justified if there is a therapeutic benefit for the patient (see section&nbsp;4.2).</p><p>&nbsp;</p><p>The plaster contains propylene glycol (E1520), methyl-4-hydroxybenzoate (Ph.&nbsp;Eur.) (E218) and propyl-4-hydroxybenzoate (Ph.&nbsp;Eur.) (E216).</p><p>Propylene glycol (E1520) may cause skin irritation.</p><p>Methyl-4-hydroxybenzoate (Ph.&nbsp;Eur.) (E218) and propyl-4-hydroxybenzoate (Ph.&nbsp;Eur.) (E216) may cause hypersensitivity reactions (possibly delayed).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No interaction studies have been performed.&nbsp; No clinically relevant interactions have been observed in clinical studies with the plaster.&nbsp; Since the maximum lidocaine plasma concentrations observed in clinical trials with the plaster were low (see section 5.2), a clinically relevant pharmacokinetic interaction is unlikely.</p><p>&nbsp;</p><p>&nbsp;</p><p>Although normally the absorption of lidocaine from the skin is low, the plaster must be used with caution in patients receiving Class&nbsp;I anti‑arrhythmic medicinal products (e.g. tocainide, mexiletine) and other local anaesthetics since the risk of additive systemic effects cannot be excluded.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Schwangerschaft</p><p>Lidocaine crosses the placenta.&nbsp; However, there are no adequate data from the use of lidocaine in pregnant women.</p><p>&nbsp;</p><p>Animal experiments do not indicate a teratogenic potential for lidocaine (see section 5.3).</p><p>&nbsp;</p><p>The potential risk for humans is unknown.&nbsp; Therefore, Versatis should not be used during pregnancy unless clearly necessary.</p><p>&nbsp;</p><p>Breast-feeding</p><p>Lidocaine is excreted in breast milk.&nbsp; However, there are no studies of the plaster in breast‑feeding women.&nbsp; Since the metabolism of lidocaine occurs relatively fast and almost completely in the liver, only very low levels of lidocaine are expected to be excreted into human milk.</p><p>&nbsp;</p><p>Fertility</p><p>No clinical data regarding fertility are available.&nbsp; Animal studies have not shown effects on female fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed.&nbsp; An effect on the ability to drive and use machines is unlikely because systemic absorption is minimal (see section 5.2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><p>&nbsp;</p><p>Approximately 16% of patients can be expected to experience adverse reactions.&nbsp; These are localised reactions due to the pharmaceutical form of the medicinal product.</p><p>&nbsp;</p><p>The most commonly reported adverse reactions were administration site reactions (such as burning, dermatitis, erythema, pruritus, rash, skin irritation, and vesicles).</p><p>The table below lists adverse reactions that have been reported in studies of post herpetic neuralgia patients receiving the plaster.&nbsp; They are listed by system organ class and frequency.</p><p>&nbsp;</p><p>The evaluation of undesirable effects is based on the following frequencies:</p><p>Very common&nbsp;&nbsp;&nbsp;&nbsp; (&ge;&nbsp;1/10)</p><p>Common&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (&ge;&nbsp;1/100 to &lt;&nbsp;1/10)</p><p>Uncommon&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (&ge;&nbsp;1/1,000 to &lt;&nbsp;1/100)</p><p>Rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (&ge;&nbsp;1/10,000 to &lt;&nbsp;1/1,000)</p><p>Very rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (&lt;&nbsp;1/10,000)</p><p>Not known &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (frequency cannot be estimated from the available data)</p><p>&nbsp;</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:499px"><tbody><tr><td style="vertical-align:top"><p><strong>Organ System</strong></p></td><td style="vertical-align:top"><p><strong>Adverse Drug Reaction</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Skin and subcutaneous tissues disorders</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Skin lesions</p></td></tr><tr><td style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Very common:</p></td><td style="vertical-align:top"><p>Administration site reactions</p></td></tr><tr><td style="vertical-align:top"><p><strong>Injury, poisoning and </strong><br /><strong>procedural complications</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Skin injuries</p></td></tr></tbody></table><p>&nbsp;</p><p>The following reactions have been observed in patients treated with the plaster under post‑marketing conditions:</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:499px"><tbody><tr><td style="vertical-align:top"><p><strong>Organ System</strong></p></td><td style="vertical-align:top"><p><strong>Adverse Drug Reaction</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Anaphylactic reaction,<br />Hypersensitivity</p></td></tr><tr><td style="vertical-align:top"><p><strong>Injury, poisoning and </strong><br /><strong>procedural complications</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Open wounds</p></td></tr></tbody></table><p>&nbsp;</p><p>All adverse reactions were predominantly of mild and moderate intensity.&nbsp; Of those, less than 5% lead to treatment discontinuation.</p><p>&nbsp;</p><p>Systemic adverse reactions following the appropriate use of the plaster are unlikely since the systemic concentration of lidocaine is very low (see section 5.2).&nbsp; Systemic adverse reactions to lidocaine are similar in nature to those observed with other amide local anaesthetic agents (see section 4.9).</p><p>&nbsp;</p><p>Reporting of suspected adverse reactions</p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important.&nbsp; It allows continued monitoring of the benefit/risk balance of the medicinal product.&nbsp; Healthcare professionals are asked to report any suspected adverse reactions via the:</p><p>&nbsp;</p><p>Bundesinstitut fuer Arzneimittel und Medizinprodukte<br />Abt. Pharmakovigilanz</p><p>Kurt-Georg-Kiesinger Allee 3 D-53175 Bonn (Germany)</p><p>Website: http://www.bfarm.de</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Overdose with the plaster is unlikely but it cannot be excluded that inappropriate use, such as use of a higher number of plasters at the same time, with prolonged application period, or using the plaster on broken skin, might result in higher than normal plasma concentrations.&nbsp; Possible signs of systemic toxicity will be similar in nature to those observed after administration of lidocaine as a local anaesthetic agent, and may include the following signs and symptoms:</p><p>Dizziness, vomiting, somnolence, seizures, mydriasis, bradycardia, arrhythmia, and shock.</p><p>&nbsp;</p><p>In addition, known drug interactions related to systemic lidocaine concentrations with beta‑blockers, CYP3A4 inhibitors (e.g. imidazole derivatives, macrolides) and anti‑arrhythmic agents might become relevant with overdose.</p><p>&nbsp;</p><p>In case of suspected overdose the plaster should be removed and supportive measures taken as clinically needed. &nbsp;There is no antidote to lidocaine.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Local anaesthetic agents, amides.</p><p>ATC code: N01 BB02</p><p>Mechanism of action</p><p>Versatis has a dual mode of action: the pharmacological action of lidocaine diffusion and the mechanical action of the hydrogel plaster that protects the hypersensitive area.</p><p>The lidocaine contained in the Versatis plaster diffuses continuously into the skin, providing a local analgesic effect.&nbsp; The mechanism by which this occurs is due to stabilisation of neuronal membranes, which is thought to cause down regulation of sodium channels resulting in pain reduction.</p><p>&nbsp;</p><p>Clinical efficacy</p><p>Pain management in post‑herpetic neuralgia (PHN) is difficult. &nbsp;From clinical studies, there is evidence of efficacy with Versatis in the symptomatic relief from the allodynic component of PHN in some cases (see section 4.2).</p><p>Efficacy of Versatis has been shown in post-herpetic neuralgia studies.</p><p>There were two main controlled studies carried out to assess the efficacy of the lidocaine 700&nbsp;mg medicated plaster.</p><p>In the first study, patients were recruited from a population who were already considered to respond to the product. &nbsp;It was a cross‑over design of 14&nbsp;days treatment with lidocaine 700&nbsp;mg medicated plaster followed by placebo, or vice versa. &nbsp;The primary endpoint was the time to exit, where patients withdrew because their pain relief was two points lower than their normal response on a six point scale (ranging from worse to complete relief). &nbsp;There were 32&nbsp;patients, of whom 30 completed. &nbsp;The median time to exit for placebo was 4&nbsp;days and for active was 14&nbsp;days (p-value &lt; 0.001); none of those on active discontinued during the two week treatment period.</p><p>&nbsp;</p><p>In the second study 265 patients with post-herpetic neuralgia were recruited and allocated to eight weeks of open label active treatment with lidocaine 700&nbsp;mg medicated plaster. &nbsp;In this uncontrolled study, approximately 50% of patients responded to treatment as measured by at least four points on a six‑point scale (ranging from worse to complete relief). &nbsp;A total of 71&nbsp;patients were randomised to receive either placebo or lidocaine 700&nbsp;mg medicated plaster given for 2-14 days. &nbsp;The primary endpoint was defined as lack of efficacy on two consecutive days because their pain relief was two points lower than their normal response on a six‑point scale (ranging from worse to complete relief) leading to withdrawal of treatment. &nbsp;There were 9&nbsp;of 36&nbsp;patients on active and 16 of 35&nbsp;patients on placebo who withdrew because of lack of treatment benefit.</p><p>Post‑hoc analyses of the second study showed that the initial response was independent of the duration of pre-existing PHN. &nbsp;However, the notion that patients with longer duration of PHN (&gt;&nbsp;12&nbsp;months) do benefit more from active treatment is supported by the finding that this group of patients was more likely to drop out due to lack of efficacy when switched to placebo during the double-blind withdrawal part of this study.</p><p>In a controlled open-label study, Versatis suggested comparable efficacy to pregabalin in 98&nbsp;patients with PHN with a favourable safety profile.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption</p><p>When lidocaine 700&nbsp;mg medicated plaster is used according to the maximum recommended dose (3 plasters applied simultaneously for 12&nbsp;h), about 3 &plusmn; 2% of the total applied lidocaine dose is systemically available and similar for single and multiple administrations.</p><p>A population kinetics analysis of the clinical efficacy studies in patients suffering from PHN revealed a mean maximum concentration for lidocaine of 45&nbsp;ng/ml after application of 3&nbsp;plasters simultaneously 12&nbsp;h per day after repeated application for up to one year.&nbsp; This concentration is in accordance with the observation in pharmacokinetic studies in PHN patients (52&nbsp;ng/ml) and in healthy volunteers (85&nbsp;ng/ml and 125&nbsp;ng/ml).</p><p>For lidocaine and its metabolites MEGX, GX, and 2,6-xylidine no tendency for accumulation was found, steady state concentrations were reached within the first four days.</p><p>The population kinetic analysis indicated that when increasing the number from 1 to 3&nbsp;plasters worn simultaneously, the systemic exposure increased less than proportionally to the number of used plasters.</p><p>Distribution</p><p>After intravenous administration of lidocaine to healthy volunteers, the volume of distribution was found to be 1.3 &plusmn; 0.4&nbsp;l/kg (mean &plusmn; S.D., n = 15). &nbsp;The lidocaine distribution volume showed no age-dependency, it is decreased in patients with congestive heart failure and increased in patients with liver disease. &nbsp;At plasma concentrations produced by application of the plaster approximately 70% of lidocaine is bound to plasma proteins. &nbsp;Lidocaine crosses the placental and blood brain barriers, presumably by passive diffusion.</p><p>&nbsp;</p><p>Biotransformation</p><p>Lidocaine is metabolised rapidly in the liver to a number of metabolites.&nbsp; The primary metabolic route for lidocaine is N-dealkylation to monoethylglycinexylidide (MEGX) and glycinexylidide (GX), both of which are less active than lidocaine and available in low concentrations.&nbsp; These are hydrolysed to 2,6-xylidine, which is converted to conjugated 4-hydroxy-2,6-xylidine.</p><p>&nbsp;</p><p>The metabolite, 2,6-xylidine, has unknown pharmacological activity but shows carcinogenic potential in rats (see section 5.3).&nbsp; A population kinetics analysis revealed a mean maximum concentration for 2,6-xylidine of 9&nbsp;ng/ml after repeated daily applications for up to one year.&nbsp; This finding is confirmed by a phase I pharmacokinetic study.&nbsp; Data on lidocaine metabolism in the skin are not available.</p><p>&nbsp;</p><p>Elimination</p><p><strong><em>&nbsp;</em></strong></p><p>Lidocaine and its metabolites are excreted by the kidneys.&nbsp; More than 85% of the dose is found in the urine in the form of metabolites or active substance.&nbsp; Less than 10% of the lidocaine dose is excreted via the kidney unchanged.&nbsp; The main metabolite in urine is a conjugate of 4‑hydroxy‑2,6-xylidine, accounting for about 70 to 80% of the dose excreted in the urine.&nbsp; 2,6&nbsp;xylidine is excreted in the urine in man at a concentration of less than 1% of the dose.&nbsp; The elimination half-life of lidocaine after plaster application in healthy volunteers is 7.6 hours.&nbsp; The excretion of lidocaine and its metabolites may be delayed in cardiac, renal or hepatic insufficiency.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Effects in non-clinical general toxicity studies were observed only at exposures considered sufficiently in excess of the maximum human exposure indicating little relevance to clinical use.</p><p>Lidocaine hydrochloride has shown no genotoxicity when investigated in vitro or in vivo.&nbsp; Its hydrolysis product and metabolite, 2,6-xylidine, showed mixed genotoxic activity in several assays, particularly after metabolic activation.</p><p>Carcinogenicity studies have not been performed with lidocaine.&nbsp; Studies performed with the metabolite 2,6-xylidine mixed in the diet of male and female rats resulted in treatment-related cytotoxicity and hyperplasia of the nasal olfactory epithelium and carcinomas and adenomas in the nasal cavity were observed.&nbsp; Tumorigenic changes were also found in the liver and subcutis.&nbsp; Because the risk to humans is unclear, long-term treatment with high doses of lidocaine should be avoided.</p><p>Lidocaine had no effect on general reproductive performance, female fertility or embryo-foetal development/teratogenicity in rats at plasma concentrations up to more than 50-fold those observed in patients.</p><p>Animal studies are incomplete with respect to male fertility, parturition or postnatal development.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Self-adhesive layer: </strong></p><p>Glycerol</p><p>Liquid sorbitol, 70%-conc.</p><p>Carmellose sodium</p><p>Propylene glycol (E1520)</p><p>Urea</p><p>Heavy kaolin / white clay</p><p>Tartaric acid (Ph.&nbsp;Eur.)</p><p>Gelatine</p><p>Polyvinyl alcohol</p><p>Aluminium glycinate dihydroxide</p><p>Sodium edetate (Ph. Eur.)</p><p>&nbsp;</p><p>Methyl-4-hydroxybenzoate (Ph. Eur.) (E218)</p><p>Propyl-4-hydroxybenzoate (Ph. Eur.) (E216)</p><p>Polyacrylic acid</p><p>Sodium polyacrylate</p><p>Purified water.</p><p>Backing fabric:</p><p>Polyethylene terephthalate</p><p>&nbsp;</p><p>Protective release liner:</p><p>Polyethylene terephthalate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years.

Shelf life after first opening of the sachet:  14 days

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not refrigerate or freeze.</p><p>After first opening:&nbsp; Keep the sachet tightly closed to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Re-sealable sachet composed of paper/polyethylene/aluminium/ethylene meta-acrylic acid co‑polymer containing 5 plasters.</p><p>Each pack contains 5, 10, 20, 25 or 30 plasters.</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After use, the plaster still contains active substance.&nbsp; After removal, the used plasters should be folded in half (adhesive side inwards so that the self-adhesive layer is not exposed), and the plaster should be discarded.</p><p>Any unused product or waste material should be disposed of in accordance with local requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Grünenthal GmbH Zieglerstrasse 6
52078 Aachen (Germany)

Phone: +49 (0)241 569-1111
Fax:  +49 (0)241 569-1112
Email: service@grunenthal.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                December 2017
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>